ProCE Banner Activity

Applying Evidence-Based Strategies to Improve Outcomes in HER2-Negative Early Breast Cancer

Slideset

Download these slides for a comprehensive overview of recent advances in the treatment of HER2-negative early breast cancer.

Released: April 29, 2024

Expiration: April 28, 2025

Share

Provided by

Provided by ProCE, LLC, in partnership with Clinical Care Options

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Merck Sharp & Dohme LLC.

AstraZeneca

Merck Sharp & Dohme, LLC

Partners

Clinical Care Options, LLC

ProCE Banner